Behavior Disorders
30
4
4
19
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.7%
2 terminated out of 30 trials
90.5%
+4.0% vs benchmark
0%
0 trials in Phase 3/4
11%
2 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (30)
Attention Deficit Hyperactivity Disorder
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Remote Training in Rural Schools
Sustainment of Mental Health Supports
Evaluation of a Remote Training Strategy
A Transdiagnostic Mentalization-based Intervention for Parents With Mental Disorders
Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact
Effect of Deep Propioceptive Stimulation in Prader-Willi Syndrome
The Safety-Net Approach
Evaluation of Safe Use of SECURIDRAP® SELFIA®
Strongest FamiliesTM Neurodevelopmental
Impact and Influence of the Use of Hypnosis Adapted to People With Severe Stage Neurocognitive Disorder (HAPNeSS) on the Professional Practices of EHPAD (Establishment for Dependent Elderly People) Caregivers With Elderly Residents
Teachers and Parents as Partners During Middle School RCT
Up To Me: Erasing the Stigma of Mental Illness on College Campuses
Strengthening Social, Emotional and Behavioral Resilience
School Withdrawal in Adolescents
The Use of Dexmedetomidine for EEG Sedation in Children With Behavioural Disorders
Recovery Roadmap Phase II Small Business Innovation Research Grant
Clinical Situations Leading to the Prescription of Neuroleptics by General Practitioner in the Elderly. Practice Survey
Perinatal Mental Health Care in Switzerland